Contract facts
NONEGENERAL NUC MED RX DOSE ADDITIONS OF DETECTNET AND LYMPHOSEEK RADIOPHARM GENERAL RX is a federal NONE award for 250-Network Contract Office 10 (36C250) held by Cardinal Health 414, LLC. Estimated value —. Related solicitation 36C25021Q0839.
GENERAL NUC MED RX DOSE ADDITIONS OF DETECTNET AND LYMPHOSEEK RADIOPHARM GENERAL RX
Incumbent footprint
Public recordCardinal Health 414, LLC — $77.1M obligated across 461 awards (firm-wide, all agencies) · lead buyer Department of Veterans Affairs (VA).
Related awards
Same incumbentQuery this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →
Frequently asked questions
What is contract 36C25022D0009?
36C25022D0009 (General NUC MED RX DOSE additions) is a 250-Network Contract Office 10 (36C250) award with an estimated value of —, currently held by Cardinal Health 414, LLC. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.
What is 36C250-22-D-0009?
36C250-22-D-0009 is the dashed form of PIID 36C25022D0009 (General NUC MED RX DOSE additions), held by Cardinal Health 414, LLC. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.
Which office awarded 36C25022D0009?
250-Network Contract Office 10 (36C250) awarded 36C25022D0009 to Cardinal Health 414, LLC.
Who is the incumbent on 36C25022D0009?
Cardinal Health 414, LLC is the incumbent with $77.1M across 461 related awards in SCOUT’s public footprint.
When does Cardinal Health 414, LLC’s 36C25022D0009 come up for recompete?
SCOUT tracks a period-of-performance end of an unstated date. Actual solicitation timing can shift with extensions, bridges, or consolidations.
Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.